Article
Ex vivo Ikkβ ablation rescues the immunopotency of mesenchymal stromal cells from diabetics with advanced atherosclerosis.
Cardiovascular research - 22 Feb 2021
Kizilay Mancini Ozge, Huynh David N, Menard Liliane, Shum-Tim Dominique, Ong Huy, Marleau Sylvie, Colmegna Ines, Servant Marc J
Abstract excerpt
AIMS: Diabetes is a conventional risk factor for atherosclerotic cardiovascular disease and myocardial infarction (MI) is the most common cause of death among these patients. Mesenchymal stromal cells (MSCs) in patients with type 2 diabetes mellitus (T2DM) and atherosclerosis have impaired ability to suppress activated T-cells (i.e. reduced immunopotency). This is mediated by an inflammatory shift in MSC-secreted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
